{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T13:00:52Z","timestamp":1750597252102,"version":"3.38.0"},"reference-count":25,"publisher":"Informa UK Limited","issue":"1","funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Xenobiotica"],"published-print":{"date-parts":[[2025,1,2]]},"DOI":"10.1080\/00498254.2024.2442431","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T08:23:31Z","timestamp":1734078211000},"page":"37-42","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Effects of CYP3A5 polymorphism and renal impairment on the drug interaction between venetoclax and fluconazole in acute myeloid leukaemia patients"],"prefix":"10.1080","volume":"55","author":[{"given":"Takahiro","family":"Kobayashi","sequence":"first","affiliation":[{"name":"Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine","place":["Akita, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honami","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine","place":["Akita, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Akamine","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Akita University Hospital","place":["Akita, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yayoi","family":"Fukushi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Akita University Hospital","place":["Akita, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine","place":["Akita, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatomo","family":"Miura","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Akita University Hospital","place":["Akita, Japan"]},{"name":"Department of Pharmacokinetics, Akita University Graduate School of Medicine","place":["Akita, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,12,20]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2017.01.003"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V62242"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2964"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061094"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2012971"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-08-868752"},{"key":"e_1_3_3_8_1","unstructured":"FDA Food and Drug Administration (US). 2024. Pharmacokinetics in patients with impaired renal function \u2013 study design data analysis and impact on dosing. [accessed 2024 Dec 6] https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/pharmacokinetics-patients-impaired-renal-function-study-design-data-analysis-and-impact-dosing."},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/chromsci\/bmac080"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.2248"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.107.018382"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000952"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-024-04673-5"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02931-15"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.116.071613"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2850"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.11.33"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389200215666141125121511"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku169"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33508"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13807"},{"key":"e_1_3_3_22_1","unstructured":"[TGA] Therapeutic Goods Department Australian Government Department of Health. 2017. Australian public assessment report for venetoclax. [accessed 2024 Dec 6]. https:\/\/www.tga.gov.au\/sites\/default\/files\/auspar-venetoclax-171109.pdf."},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1990.tb03623.x"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1996.45111.x"},{"key":"e_1_3_3_25_1","volume-title":"Drug interview form","author":"Venetoclax (VENCLEXTA)","year":"2021","unstructured":"Venetoclax (VENCLEXTA). 2021. Drug interview form. Tokyo, Japan: AbbVie GK. [accessed 2024 Dec 6]. https:\/\/a-connect.abbvie.co.jp\/-\/media\/assets\/pdf\/products\/venclexta\/if_Venclexta_j.pdf. Japanese."},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01600"}],"container-title":["Xenobiotica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/00498254.2024.2442431","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T06:02:10Z","timestamp":1741154530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/00498254.2024.2442431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,20]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,2]]}},"alternative-id":["10.1080\/00498254.2024.2442431"],"URL":"https:\/\/doi.org\/10.1080\/00498254.2024.2442431","relation":{},"ISSN":["0049-8254","1366-5928"],"issn-type":[{"type":"print","value":"0049-8254"},{"type":"electronic","value":"1366-5928"}],"subject":[],"published":{"date-parts":[[2024,12,20]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ixen20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ixen20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-11-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}